| human | Q5 |
| P9984 | CANTIC ID | 981058524791806706 |
| P11496 | CiNii Research ID | 1140563741662985728 |
| P6178 | Dimensions author ID | 011513347337.73 |
| P269 | IdRef ID | 068689136 |
| P213 | ISNI | 0000000117528192 |
| P244 | Library of Congress authority ID | n95803020 |
| P271 | NACSIS-CAT author ID | DA09778789 |
| P8189 | National Library of Israel J9U ID | 987007329085905171 |
| P691 | NL CR AUT ID | xx0204238 |
| P1207 | NUKAT ID | n2003090577 |
| P496 | ORCID iD | 0000-0003-0916-6042 |
| P3368 | Prabook ID | 3433183 |
| P11686 | University of Barcelona authority ID | 981058524791806706 |
| P1580 | University of Barcelona authority ID (former scheme) | a1317353 |
| P214 | VIAF ID | 26319159 |
| P108 | employer | Baylor University Medical Center | Q4874614 |
| P101 | field of work | medicine | Q11190 |
| transplantology | Q1049976 | ||
| surgery | Q40821 | ||
| P735 | given name | Goran | Q1537844 |
| Goran | Q1537844 | ||
| P1412 | languages spoken, written or signed | English | Q1860 |
| P106 | occupation | researcher | Q1650915 |
| transplant surgeon | Q7834824 | ||
| P21 | sex or gender | male | Q6581097 |
| Q33752310 | A Meta-Analysis for Comparison of the Two-Layer and University of Wisconsin Pancreas Preservation Methods in Islet Transplantation |
| Q36091792 | A comparison of tacrolimus and cyclosporine in liver transplantation: effects on renal function and cardiovascular risk status |
| Q37308037 | A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus |
| Q30441628 | Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis |
| Q37064446 | Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity. |
| Q30438585 | Central nervous system cryptococcosis in solid organ transplant recipients: clinical relevance of abnormal neuroimaging findings |
| Q36023899 | Circulating TGF-β1 and VEGF and risk of cancer among liver transplant recipients |
| Q30438524 | Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality |
| Q34021345 | Development and validation of GFR-estimating equations using diabetes, transplant and weight |
| Q37426836 | Differential effects of donor and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantation |
| Q28194251 | Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders |
| Q30426041 | Identifying predictors of central nervous system disease in solid organ transplant recipients with cryptococcosis |
| Q33989198 | Impact of pretransplant hyponatremia on outcome following liver transplantation |
| Q37964621 | Implications of a positive crossmatch in liver transplantation: a 20-year review |
| Q37650993 | Indications for combined liver and kidney transplantation: propositions after a 23-yr experience |
| Q30433949 | Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis |
| Q30276330 | Liver Resection and Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria |
| Q34802516 | Liver transplantation in association with hepatocellular carcinoma: an update of the International Tumor Registry |
| Q34145453 | One Hundred Human Pancreatic Islet Isolations at Baylor Research Institute |
| Q36955936 | Pancreatic islet cell transplantation: update and new developments |
| Q37680624 | Predicting renal failure after liver transplantation from measured glomerular filtration rate: review of up to 15 years of follow-up |
| Q35916220 | Preoperative and perioperative predictors of the need for renal replacement therapy after orthotopic liver transplantation |
| Q35645422 | Pseudohypocalcemia after magnetic resonance imaging with gadolinium in patients with cirrhosis |
| Q30426015 | Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen |
| Q36163184 | Rabies encephalomyelitis: clinical, neuroradiological, and pathological findings in 4 transplant recipients |
| Q34618726 | Ratio of hepatic arterial flow to recipient body weight predicts biliary complications after deceased donor liver transplantation |
| Q38056635 | Renal-sparing regimens employing new agents |
| Q34470784 | Successful combined liver and kidney transplant for COACH syndrome and 5-yr follow-up |
| Q30300505 | Surgical treatment of hepatocellular carcinoma in North America: can hepatic resection still be justified? |
| Q36480391 | The Baylor Regional Transplant Institute: review of a twenty-year experience. |
| Q37639714 | The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence |
| Q89851400 | The molecular diagnosis of rejection in liver transplant biopsies: First results of the INTERLIVER study |
| Q117069557 | The molecular phenotypes of injury, steatohepatitis, and fibrosis in liver transplant biopsies in the INTERLIVER study |
| Q28192214 | Thrombendvenectomy for organized portal vein thrombosis at the time of liver transplantation |
| Q34405605 | Transmission of rabies virus from an organ donor to four transplant recipients |
| Q35719476 | Two-stage total hepatectomy and liver transplantation for acute deterioration of chronic liver disease: a new bridge to transplantation |
Search more.